Nvidia also said Wednesday that the H20 licensing requirements will result in an $8 billion hit to the company’s revenue in Q2, which is predicted to be around $45 billion — a significant toll.

The US expanded semiconductor restrictions to include Nvidia's H20 chip, previously the only compliant AI processor available to Chinese buyers, as the Trump administration deepens technology ...

Nvidia had to write down $4.5 billion in charges related to the Trump administration's ban on sales of its H20 chip to China. The company announced the news in an April regulatory filing.

Trump tightens China chip curbs as Nvidia's H20 faces new export limits. China reportedly stockpiled US$12B worth of Nvidia H20 chips ahead of US ban.

H20 export curbs trim USD 8B from Nvidia's Q2 guidance Nvidia's second-quarter outlook reflects continued headwinds from export restrictions. The company expects revenue of approximately USD 45 ...

TL;DR: NVIDIA faces significant revenue losses due to new U.S. export restrictions cutting off access to the Chinese datacenter market, impacting billions in H20 GPU sales. Despite setbacks, CEO ...

That number falls short of Nvidia’s over 1 million China-specific H20 chips produced in the last nine months of 2024, analysts estimate. Advertisement. US-China tech war. Tech Tech War.

Nvidia stock's bullish with strong technicals ahead of earnings, but supply woes cloud the outlook. H20 chip delays and China export issues may pressure guidance, though long-term demand remains ...

The chip giant reported that it lost $2.5 billion of H20 revenue in the quarter. Nvidia stock rose in after-hours trading Wednesday, bouncing between a 4% and 5% gain after the bell.

May 28 - Nvidia (NASDAQ:NVDA) may face near-term estimate risk as Wall Street models appear to overlook the impact of new U.S. restrictions on H20 GPU shipments to China, according to Morgan Stanley..

Dubai – A group of six students from the German International School Dubai (DISD) were honored today at the prestigious H20 Summit at the WHO headquarters in Geneva.Launched in 2018 by the G20 Health ...

Revenue: $44.1 billion, up 69% from a year ago vs. $43.3 billion expected Adjusted EPS: 81 cents, up 33% from a year ago vs. 73 cents expected. Q2 guidance: Revenue of $45.0 billion vs. $45.9 ...